Underwater Endoscopic Mucosal Resection a Learning Curve Study
Study Details
Study Description
Brief Summary
The global aim of this multi-centric study is to assess the learning curve of U-EMR by an endoscopist skilled in C-EMR aiming to assess the application in real world and check the rate of complete EMR and adverse events related to the procedure.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Conventional Endoscopic mucosal resection (C-EMR) is currently the standard therapy for the removal of large colon polyps. The procedure consists on the injection of fluids into the submucosa layer below the lesion with the intention to create a cushion to separate it from the muscular layer and avoid its damage and consequently perforation and thermal injury. There are some drawbacks about this technique such us fibrotic polyps, difficult location (areas behind the fold and appendicular orifice) and recurrence rate which without ablation techniques could reach 30%.
Underwater endoscopic mucosal resection (U-EMR) has been first described in 2012 by Binmoeller et al [10] and the main difference to C-EMR was the absence of need the submucosal injection. This would be possible because when the lumen is filled with water, the mucosal and the submucosal layer tend to float while the muscularis propria maintains its circular shape even in the presence of peristalsis. Recent data as shown not only a lower rate of recurrence but also a lower procedure time and R0 resections with no difference in adverse events.
Therefore, the global aim of this multi-centric study is to assess the learning curve of U-EMR by an endoscopist skilled in C-EMR aiming to assess the application in real world and check the rate of complete EMR and adverse events related to the procedure.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Underwater mucosectomy Every colonoscopy should be performed with a high definition colonoscope, such as Olympus series Q185 or Q190 with virtual chromoendoscopy by NBI (Olympus Inc., Tokyo, Japan) or Fujifilm EC-760R-V/L or EC-760Z-V/L with virtual chromoendoscopy by LBI (Fujifilm Group, Japan). A study investigator or a senior endoscopy fellow under their direct supervision should perform all procedures. The U-EMR procedure should include the following steps: CO2 should be completely removed, and the bowel lumen filled with normal saline using a water jet pump (OFP-2, Olympus Medical System or similar) until the lesion is totally immersed in water. The lesion and 2-3 mm of normal surrounding mucosa should be resected using electrocauterization (VIO 200D Endocut Q Effect 3; ERBE Electromedizin, Tübingen, Germany). |
Other: learning curve of Underwater mucosectomy
Patients will be submitted to underwater mucosectomy (U-EMR)
|
Outcome Measures
Primary Outcome Measures
- learning curve of the application of U-EMR by endoscopists skilled in C-EMR [6 months]
evaluate the learning curve of the application of U-EMR by endoscopists skilled in C-EMR after an online course about U-EMR technique.
Eligibility Criteria
Criteria
Inclusion Criteria: all outpatients referred to perform EMR who comply with:
- Age: 18 years-old or older II. At least one large (>10 and <30 mm) non pedunculated polyp III.Agreement with study's procedures, having signed the informed consent for the study and EMR, prior to the procedure
Exclusion Criteria:
- Previous attempted resection II. Lesion located at ileo-cecal valve or appendiceal orifice III. Fully circumferential lesion IV. Pedunculated polyps (Paris classification type Ip) and ulcerated depression lesions (Paris classification type III) V. Surface pattern suggestive of deep invasion (ex: narrow-band imaging (NBI) International Colorectal Endoscopic (NICE) classification type 3 criteria, Kudo V or equivalent) VI. Invasive cancer at EMR specimen VII. Inflammatory bowel disease VIII. Familial polyposis syndrome
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Instituto Portugues Oncologia de Lisboa Francisco Gentil
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- UIC/1593